Zotepine loading in acute and severely manic patients: A pilot study

Bipolar Disorders

Volumn 7, Issue 5, 2005, Pages 471-476

  Amann, Benedikt Lorenz ^a   Sterr, Andrea ^a   Mergl, Roland ^a   Dittmann, Sandra ^a   Seemüller, Florian ^a   Dobmeier, Matthias ^b   Orth, Michael ^b   Schaefer, Martin ^c   Grunze, Heinz ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b Department of Psychiatry ^*  (United Kingdom)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Anticonvulsants; Antipsychotics; Bipolar disorder; Mania; Zotepine

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; DIAZEPAM; OXAZEPAM; PERAZINE; RISPERIDONE; TRIMIPRAMINE; VALPROIC ACID; ZOTEPINE;

ACUTE DISEASE; ADULT; AKATHISIA; AKINESIA; ARTICLE; AUTONOMIC NEUROPATHY; BODY WEIGHT; BODY WEIGHT DISORDER; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; DOSE RESPONSE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DYSARTHRIA; DYSKINESIA; EDEMA; EEG ABNORMALITY; EPILEPTIC DISCHARGE; EXTRAPYRAMIDAL SYMPTOM; EYE DISEASE; FEMALE; HAMILTON SCALE; HEADACHE; HUMAN; HYPERTENSION; LIBIDO DISORDER; LIVER DYSFUNCTION; LOADING TEST; MALE; MANIA; MICTURITION DISORDER; MONOTHERAPY; MOTOR DYSFUNCTION; MOUTH DISEASE; MUSCLE RIGIDITY; NAUSEA; OPEN STUDY; PATIENT CODING; PHOTOSENSITIVITY; PILOT STUDY; POLYURIA; PRIORITY JOURNAL; RATING SCALE; SCORING SYSTEM; SEDATION; SOMNOLENCE; TACHYCARDIA; TREMOR; WEIGHT GAIN; WEIGHT REDUCTION; XEROSTOMIA;

ACUTE DISEASE; ADULT; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIBENZOTHIEPINS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; PILOT PROJECTS; SEVERITY OF ILLNESS INDEX;

EID: 26444459401     PISSN: 13985647     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-5618.2005.00241.x     Document Type: Article

References (26)

1. Bowden CL, Brugger AM, Swann AC et al. Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group. JAMA 1994; 271:918-924.
2. Vasudev K, Goswami U, Kohli K. Carbamazepine and valproate monotherapy: feasibility, relative safety and efficacy, and therapeutic drug monitoring in manic disorder. Psychopharmacology (Berl) 2000; 150: 15-23.
3. Post RM, Ketter TA, Pazzaglia PJ et al. Rational polypharmacy in the bipolar affective disorders. Epilepsy Res Suppl 1999; 11: 153-180.
4. Tohen M, Ketter TA, Zarate CA et al. Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study. Am J Psychiatry 2003; 160: 1263-1271.
5. Tohen M, Jacobs TG, Grundy SL et al. Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group. Arch Gen Psychiatry 2000; 57: 841-849.
6. Tohen M, Sanger TM, McElroy SL et al. Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group. Am J Psychiatry 1999; 156: 702-709.
7. Yatham LN, Binder C, Riccardelli R, Leblanc J, Connolly M, Kusumakar V. Risperidone in acute and continuation treatment of mania. Int Clin Psychopharmacol 2003; 18: 227-235.
8. Khanna S, Vieta E, Lyons B, Grossman F, Kramer M. Risperidone in the treatment of acute bipolar mania: a double-blind, placebo-controlled study of 290 patients. Eur Neuropsychopharmacol 2003; 13 (Suppl. 4): 314-315.
9. Rush AJ, Pincus HA, First MB et al. Psychiatric Measures. Washington, D.C.: American Psychiatric Association, 2000.
10. Brotman MA, Fergus EL, Post RM, Leverich GS. High exposure to neuroleptics in bipolar patients: a retrospective review. J Clin Psychiatry 2000; 61: 68-72; quiz 73.
11. Nasrallah HA, Churchill CM, Hamdan-Allan GA. Higher frequency of neuroleptic-induced dystonia in mania than in schizophrenia. Am J Psychiatry 1988; 145: 1455-1456.
12. Mukherjee S, Rosen AM, Caracci G, Shukla S. Persistent tardive dyskinesia in bipolar patients. Arch Gen Psychiatry 1986; 43: 342-346.
13. Möller HJ. Zotepine - an antipsychotic with atypical profile. PPT 2000; 2: 70-74.
14. Petit M, Raniwalla J, Tweed J, Leutenegger E, Dollfus S, Kelly F. A comparison of an atypical and typical antipsychotic, zotepine versus haloperidol in patients with acute exacerbation of schizophrenia: a parallel-group double-blind trial. Psychopharmacol Bull 1996; 32: 81-87.
15. Harada T, Otsuki S. Antimanic effect of zotepine. Clin Ther 1986; 8: 406-414.
16. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorder, 4th edn. Washington, D.C.: American Psychiatric Association, 1994.
17. First MB, Spitzer RL, Williams JBW, Gibbon M. Structured Clinical Interview for DSM-IV (SCID). Washington, D.C.: American Psychiatric Association, 1995.
18. Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978; 133: 429-435.
19. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967; 6: 278-296.
20. Spearing MK, Post RM, Leverich GS, Brandt D, Nolen W. Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP. Psychiatry Res 1997; 73: 159-171.
21. Dube S, Andersen S, Clemow D, Sanger T, Tohen M, Tollefson G. Olanzapine-fluoxetine combination for treatment of psychotic depression. Eur Psychiatry 2002; 17 (Suppl. 1): 130.
22. Tohen M, Vieta E, Calabrese J et al. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Arch Gen Psychiatry 2003; 60: 1079-1088.
23. Mueller-Spahn F, Dieterle DM, Ackenheil M. Clinical efficacy of zotepine in the treatment of schizophrenic negative symptoms. Fortschr Neurol Psychiatr 1991; 59 (Suppl. 1): 30-35.
24. Barnas C, Stuppack CH, Miller C, Haring C, Sperner-Unterweger B, Fleischhacker WW. Zotepine in the treatment of schizophrenic patients with prevailingly negative symptoms. A double-blind trial vs. haloperidol. Int Clin Psychopharmacol 1992; 7: 23-27.
25. Cooper SJ, Tweed J, Raniwalla J, Butler A, Welch C. A placebo-controlled comparison of zotepine versus chlorpromazine in patients with acute exacerbation of schizophrenia. Acta Psychiatr Scand 2000; 101: 218-225.
26. Cooper SJ, Butler A, Tweed J, Welch C, Raniwalla J. Zotepine in the prevention of recurrence: a randomised, double-blind, placebo-controlled study for chronic schizophrenia. Psychopharmacology (Berl) 2000; 150: 237-243.